Baltimore startup Delfi Diagnostics raises $225M with plans to change how lung cancer is diagnosed

Delfi Diagnostics' blood test for lung cancer is backed by some of the biggest names in Baltimore, such as T. Rowe Price Associates and Brown Advisory.